Evidence map›Paper›PMID 27146795›Full record

ArticleScientific reports2016

A Novel Protective Function of 5-Methoxytryptophan in Vascular Injury.

Yen-Chun Ho, Meng-Ling Wu, Chen-Hsuan Su, Chung-Huang Chen, Hua-Hui Ho, Guan-Lin Lee, Wei-Shiang Lin, Wen-Yu Lin, Yu-Juei Hsu, Cheng-Chin Kuo and 2 more

Abstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Characterizing the metabolic response of the zebrafish kidney to overfeeding.American journal of physiology. Renal physiology · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Cytoguardin: A Tryptophan Metabolite against Cancer Growth and Metastasis.International journal of molecular sciences · 2021
    Review
  13. Article
  14. Control of Mesenchymal Stromal Cell Senescence by Tryptophan Metabolites.International journal of molecular sciences · 2021
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yen-Chun HoInstitute of Cellular and System Medicine, National Health Research Institutes, Zhunan, Taiwan.
Meng-Ling WuInstitute of Cellular and System Medicine, National Health Research Institutes, Zhunan, Taiwan.
Chen-Hsuan SuInstitute of Cellular and System Medicine, National Health Research Institutes, Zhunan, Taiwan.
Chung-Huang ChenInstitute of Cellular and System Medicine, National Health Research Institutes, Zhunan, Taiwan.
Hua-Hui HoInstitute of Cellular and System Medicine, National Health Research Institutes, Zhunan, Taiwan.
Guan-Lin LeeInstitute of Cellular and System Medicine, National Health Research Institutes, Zhunan, Taiwan.
Wei-Shiang LinDivision of Cardiology, Department of Medicine, Tri-Service General Hospital, Taipei, Taiwan.
Wen-Yu LinDivision of Cardiology, Department of Medicine, Tri-Service General Hospital, Taipei, Taiwan.
Yu-Juei HsuDivision of Nephrology, Department of Medicine, Tri-Service General Hospital, Taipei, Taiwan.
Cheng-Chin KuoInstitute of Cellular and System Medicine, National Health Research Institutes, Zhunan, Taiwan.
Kenneth K WuInstitute of Cellular and System Medicine, National Health Research Institutes, Zhunan, Taiwan.
Shaw-Fang YetInstitute of Cellular and System Medicine, National Health Research Institutes, Zhunan, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

5-Methoxytryptophan (5-MTP), a 5-methoxyindole metabolite of tryptophan metabolism, was recently shown to suppress inflammatory mediator-induced cancer cell proliferation and migration. However, the role of 5-MTP in vascular disease is unknown. In this study, we investigated whether 5-MTP protects against vascular remodeling following arterial injury. Measurements of serum 5-MTP levels in healthy subjects and patients with coronary artery disease (CAD) showed that serum 5-MTP concentrations were inversely correlated with CAD. To test the role of 5-MTP in occlusive vascular disease, we subjected mice to a carotid artery ligation model of neointima formation and treated mice with vehicle or 5-MTP. Compared with vehicle-treated mice, 5-MTP significantly reduced intimal thickening by 40% 4 weeks after ligation. BrdU incorporation assays revealed that 5-MTP significantly reduced VSMC proliferation both in vivo and in vitro. Furthermore, 5-MTP reduced endothelial loss and detachment, ICAM-1 and VCAM-1 expressions, and inflammatory cell infiltration in the ligated arterial wall, suggesting attenuation of endothelial dysfunction. Signaling pathway analysis indicated that 5-MTP mediated its effects predominantly via suppressing p38 MAPK signaling in endothelial and VSMCs. Our data demonstrate a novel vascular protective function of 5-MTP against arterial injury-induced intimal hyperplasia. 5-MTP might be a therapeutic target for preventing and/or treating vascular remodeling.

Indexed as

AgedAnimalsArteriesCells, CulturedCoronary Artery DiseaseDisease Models, AnimalFemaleGene Expression RegulationHumansHuman Umbilical Vein Endothelial CellsMaleMAP Kinase Signaling SystemMiceMiddle AgedMuscle, Smooth, VascularMyocytes, Smooth Muscle5-methoxytryptophanTryptophan

Identifiers

PMID27146795
PMCPMC4857180

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.